New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 8, 2012
10:20 EDTTNB, SIGA, MAKO, SNCR, RHHBY, EA, SYNC, NCMI, BP, ERJ, ACM, EPOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AECOM Technology (ACM) downgraded to Underperform from Buy at BofA/Merrill... BP (BP) downgraded to Underweight from Equal Weight at Barclays... El Paso (EP) downgraded to Underweight from Neutral at Atlantic Equities... Embraer (ERJ) downgraded to Neutral from Buy at Citigroup... Mako Surgical (MAKO) downgraded to Neutral from Buy at Mizuho... National CineMedia (NCMI) downgraded to In-Line from Outperform at Imperial Capital... Roche (RHHBY) downgraded to Neutral from Overweight at JPMorgan... SIGA Technologies (SIGA) downgraded to Sector Perform from Outperform at RBC Capital... Synacor (SYNC) downgraded to Underperform from Buy at BofA/Merrill... Synchronoss (SNCR) downgraded to Market Perform from Outperform at Wells Fargo... Thomas & Betts (TNB) downgraded to Neutral from Outperform at RW Baird... Electronic Arts (EA) downgraded to Market Perform from Outperform at William Blair.
News For ACM;BP;EP;ERJ;MAKO;NCMI;RHHBY;SIGA;SYNC;SNCR;TNB;EA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
March 18, 2015
09:56 EDTBPRumor: BP strength attributed to takeover speculation
Subscribe for More Information
07:46 EDTRHHBYLilly Roche would have upbeat read through from strong BIIB data, says Bernstein
Bernstein notes that the data for Biogen's (BIIB) Alzheimer's treatment, due to be released on Friday, is widely expected to be positive. The firm thinks that positive data would boost the outlook for similar Alzheimer's drugs being developed by Eli Lilly (LLY) and Roche (RHHBY), since consensus estimates for those drugs are low. The firm keeps Outperform ratings on Eli Lilly and Roche.
07:02 EDTBPExterran nominates five new directors to board
Exterran Holdings (EXH) announced that its Board of Directors has nominated the following individuals for election to the Exterran Holdings Board at the Company’s 2015 Annual Meeting of Stockholders on April 28: Anne-Marie N. Ainsworth – former President and CEO of the general partner of Oiltanking Partners, L.P. (OILT); Frances Powell Hawes – independent financial consultant and former CFO of NCI Building Systems (NCS); James H. Lytal – independent energy consultant and former President of Gulfterra Energy Partners LP; Richard R. Stewart- former President and CEO of GE Aero Energy (GE); and Ieda Gomes Yell – Managing Director of Energix Strategy Ltd. and former President of BP Brazil (BP). “In November 2014, we announced a plan to separate Exterran’s international contract operations, international aftermarket services and global fabrication businesses into an independent, publicly traded company in the second half of 2015,” said Mark Sotir, Executive Chairman of the Board. “Our Board has nominated these additional well qualified director candidates in anticipation of certain of Exterran’s directors resigning from the Board at the time of the separation in order to join the board of directors of the new publicly traded company. We have not yet reached a final determination regarding which directors will remain on Exterran’s Board and which directors will join the board of directors of SpinCo at the time of the separation.”
March 17, 2015
11:42 EDTEAElectronic Arts Battlefield Hardline review slightly disappointing, says Cowen
Subscribe for More Information
09:11 EDTBPBP study criticized by Gulf oil spill trustees, Financial Times says
Subscribe for More Information
09:03 EDTEAElectronic Arts, Visceral Games announce availability of Battlefield Hardline
Subscribe for More Information
08:27 EDTBPBP says environmental assessment shows most spill impact of short duration
Subscribe for More Information
08:13 EDTRHHBYCelldex announces clinical trial collaboration with Roche
Celldex Therapeutics (CLDX) announced that it has entered into a clinical trial collaboration with Roche (RHHBY) to evaluate the safety, tolerability and preliminary efficacy of varlilumab, Celldex's CD27 targeting investigational antibody, and MPDL3280A, Roche's investigational cancer immunotherapy in a Phase 1/2 study in renal cell carcinoma. Varlilumab and MPDL3280A are part of a new class of investigational medicines known as cancer immunotherapies that are designed to harness the body's own immune system to fight cancer through separate yet complementary mechanisms of action that may enable the activation of T cells, restoring their ability to effectively detect and attack tumor cells. Preclinical data suggest the combination of these two mechanisms are synergistic and may enhance anti-tumor immune response compared to either agent alone. In Celldex's Phase 1 study of varlilumab in multiple solid tumors, promising signs of clinical activity in patients with refractory renal cell carcinoma were observed, including a durable partial response that has continued to decrease in tumor volume over time and prolonged stable disease. Under the terms of this agreement, Roche will provide study drug and Celldex will be responsible for conducting and funding the study, which is expected to begin in 2015.
06:47 EDTNCMINational CineMedia merger termination largely expected, says Piper Jaffray
Subscribe for More Information
06:45 EDTNCMIJustice Department says National CineMedia merger end a 'victory'
Subscribe for More Information
March 16, 2015
16:06 EDTNCMINational CineMedia sees FY15 adjusted OIBDA $210M-$220M, consensus 40c
Subscribe for More Information
16:05 EDTNCMINational CineMedia sees Q1 Adjusted OIBDA $25M-$28M, consensus (6c)
Sees Q1 revenue $75M-$78M, consensus $76.69M.
16:03 EDTNCMINational CineMedia, Screenvision terminate merger agreement
Subscribe for More Information
11:11 EDTBPOPEC sees oil prices to hit U.S. oil output by late 2015, Reuters says
Subscribe for More Information
March 15, 2015
17:49 EDTBPBP and Egypt in $12B energy deal, Reuters says
Subscribe for More Information
March 13, 2015
07:49 EDTEAVideo game hardware sales up 10% in February, software up 7%, Game Informer says
Subscribe for More Information
06:32 EDTBPIEA says oil price pressure likely to resume, Reuters reports
Subscribe for More Information
06:29 EDTBPOil companies reach tentative agreement with union, WSJ says
Subscribe for More Information
06:02 EDTBPBP to sell Australian bitumen business to Puma Energy
Subscribe for More Information
05:42 EDTEAFebruary video game software sales rose 7%, says Piper Jaffray
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use